Yamada Yuko, Yamamoto Takuji, Tanabe Kumiko, Fukuoka Naokazu, Takenaka Motoyasu, Iida Hiroki
Department of Anesthesiology and Pain Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
Department of Anesthesiology and Pain Medicine, Gifu University Graduate School of Medicine, Gifu 501-1194, Japan.
J Clin Anesth. 2016 Aug;32:30-2. doi: 10.1016/j.jclinane.2015.11.004. Epub 2016 Mar 22.
Rocuronium is the agent most frequently involved in perioperative anaphylaxis, and sugammadex has also been known to induce anaphylactic reactions. We describe a case of successive anaphylactic episodes that seemed to be induced by clinical doses of rocuronium and sugammadex. The patient was a 19-year-old woman who had a medical history of asthma, but no history of surgery. She had been injured in a fall, and several surgeries were scheduled for multiple bone fractures. At the first surgery under general anesthesia, she developed anaphylaxis 5 min after sugammadex administration. A second general anesthesia for treatment of calcaneal fracture was induced uneventfully without neuromuscular blockade after 10 days. A third general anesthesia was scheduled to reinforce the spinal column 12 days after the first surgery. She developed anaphylaxis 8 min after rocuronium administration. The level of plasma histamine was elevated, but serum tryptase level remained normal. This surgery was canceled and rescheduled without use of a neuromuscular blockade. Skin tests were performed in a later investigation. The patient showed positive results on intradermal tests for sugammadex and rocuronium, supporting a diagnosis of allergic reactions to both drugs. Clinicians must be aware that anaphylactic reactions can be induced by both sugammadex and rocuronium.
罗库溴铵是围手术期过敏反应中最常涉及的药物,而且已知舒更葡糖钠也可引发过敏反应。我们描述了一例似乎由临床剂量的罗库溴铵和舒更葡糖钠诱发的连续过敏发作病例。患者为一名19岁女性,有哮喘病史,但无手术史。她因跌倒受伤,计划进行多次手术治疗多处骨折。在首次全身麻醉手术中,给予舒更葡糖钠5分钟后她发生了过敏反应。10天后,在无神经肌肉阻滞的情况下顺利诱导进行了第二次全身麻醉以治疗跟骨骨折。首次手术后12天计划进行第三次全身麻醉以加固脊柱。给予罗库溴铵8分钟后她发生了过敏反应。血浆组胺水平升高,但血清类胰蛋白酶水平保持正常。此次手术取消并重新安排,不再使用神经肌肉阻滞剂。在后续调查中进行了皮肤试验。患者对舒更葡糖钠和罗库溴铵的皮内试验呈阳性结果,支持对这两种药物过敏反应的诊断。临床医生必须意识到舒更葡糖钠和罗库溴铵均可诱发过敏反应。